~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~

~ Panel Discussion Posted to Ensysce's Corporate Website ~

Past Winners include Waymo, Nvidia, Duolingo, and Novo Nordisk, among others

- Dermata expects to announce topline results from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial by end of March 2025 -

- The Company recently entered into a Clinical Trial Collaboration Agreement with Revance Therapeutics (recently merged with Crown Laboratories) to study DMT410 for the treatment of axillary hyperhidrosis - 

- Raised $2.55 million in gross proceeds from a private placement financing in January 2025, including participation from Dermata's Chief Executive Officer, Chief Financial Officer, and certain members of the Company's board of directors -

The creators of the sam® sustained acoustic medicine technology present its proven ability to speed recovery and soft tissue healing at the University of Louisiana basketball game, part of the company's commitment to helping athletes stay healthy.

Venerable, Popular Destination to Introduce Hypha Labs to Canadian and U.S. Investors

MedSmart Wellness Centers Inc. Signs Letter of Intent to Acquire 3,000 Sq. Ft. Facility in Tequesta, Florida

Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

The Company is Preparing for Commercialization and Evaluating Strategies to Support the Adoption of its Robotic-Assisted Technology

America's Accountant® Daniel J. Geltrude Teams Up with Furry Friends to Teach That Dogs Are Business-Savvy

Electronic Caregiver Opens Nationwide Direct Sales Opportunities for Female Entrepreneurs

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion disease

Travel Nurses, Inc. announced Becky Walker, RN from Carrollton, Mississippi, as their first quarter DAISY Award honoree for 2025.

Another key win in expanding AI Nose's industrial opportunities

Partnership to integrate AI Nose into ASE's factories and explore broader industrial use-cases

Intiva Health proudly announces itself as the parent company of three industry-leading brands: Incredable, Nova Vita, and Gummi World.

For the 14th year, Dr. Donath is celebrated for his contributions and dedication to the field of facial plastic surgery.

This Press Release is Acting as a Correction to the Financial Tables in the Previous Release

Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR)

Management to Host Business Update Conference Call on Wednesday, March 12, 2025, at 4:30 p.m. Eastern Time

Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR)

Management to Host Business Update Conference Call on Wednesday, March 12, 2025, at 4:30 p.m. Eastern Time

Survey Reveals Global Healthcare Buyers Shifting IT Purchases to Regional Providers Amid Regulatory and Geopolitical Concerns

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS

Innovative tissue spacer technology for cancer radiology treatments

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Latest investment follows previously-announced investment in TRNR of $2.9M, reflecting investor's increased enthusiasm for Company's growth and acquisition strategy, including last week's Letter of Intent

Accomplished Technology Executive and Entrepreneur Wensheng Fan Joins DeepRx Inc.

Partnership Focuses on Investigating the Use of CAMPS (Cellular, Acellular and Matrix-like Products) in Hard-to-Heal Pressure Ulcers

The lawsuit consumes valuable taxpayer-funded resources.

What is Hantavirus?  How Can I Prevent It? JP McHale Pest Management Has the Answers

Harnessing AI-Powered Scent Digitization for Smarter, Safer, and More Sustainable Factories

As the automotive and electronics industries undergo rapid transformation, HAHN Automation Group is setting new benchmarks in technological excellence. With over 30 years of experience, a strong U.S. presence, and a global network, we are uniquely positioned to address industry challenges and drive automation forward.

Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

Groundbreaking Trial on PF614-MPAR Generates Positive Interim Results

Clinical response rate of 63.5% and clinical remission rate of 30.2% achieved at Week 12 with the highest dose, which continued to improve through Week 28

All three doses met the primary endpoint of clinical response at Week 12, with a favorable safety profile

These results in ulcerative colitis build on strong data recently reported for the plaque psoriasis Phase 3 program

Nearly half of patients with moderate-to-severe plaque psoriasis (PsO) treated with icotrokinra achieved completely clear skin (IGA 0) at Week 24 in Phase 3 ICONIC-LEAD study

Topline results from Phase 3 ICONIC-ADVANCE 1&2studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe PsO

Results pave the way to initiate the first-ever head-to-head study (ICONIC-ASCEND) seeking to demonstrate the superiority of a pill versus injectable biologic in moderate-to-severe PsO

Unveiled revolutionary AI Nose for robotics application, inviting global robotics companies to join Ainos Alliance in shaping the future of smell-enabled robots

Advanced VELDONA^® development with key Japan patent, Taiwan Tanabe partnership, and IRB approval for Sjögren's syndrome clinical study

Practical partnership for AI Nose, multiple new opportunities

AI Nose to change robotics landscape with first AI smell sensing

Increasing Patient Wellness With Thoughtful Connections

2025 American Medical Informatics Association Summit "Uniting Data-Driven Informatics" Set for March 10-13 in Pittsburgh

Azalea House Hospitality Offers Masters Tickets

23-Year-Old Influencer Receives a Double-Lung Transplant From the FBI